Skip to main content

Table 2 Parameter values and plausible ranges for cost estimates per case used in the baseline and sensitivity analysis (Int $)

From: Cost-effectiveness analysis of neonatal hearing screening program in china: should universal screening be prioritized?

Items Hearing screening method Baseline Ranges for sensitivity analysis
    Minimum Maximum
Screening     
   Program costs     
   Capital costs OAE 240,813,700 170,712,610 307,291,540
  OAE+AABR 429,951,870 322,027,570 559,461,040
   Recurrent costs OAE 150 100 200
  OAE+AABR 230 130 360
   Patient costs   30 10 50
Diagnosis     
   Program costs     
   Capital costs   15,950,600 11,014,773 21,467,600
   Recurrent costs   240 130 360
   Patient costs   170 90 310
Intervention     
   Program costs     
   Capital costs   13,829,240 12,430,260 15,554,540
   Recurrent costs   290 200 440
   Patient costs   22,690 18,860 29,140
  1. Abbreviation: Otoacoustic emission (OAE); Automated auditory brainstem response (AABR)